Pesquisar
Hoth Therapeutics Inc
HOTHAdicionar à lista de desejos
1.360USD
0.0000.00%
Horário de mercado （ET）Cotações atrasadas em 15 min
21.02MValor de mercado
PerdaP/L TTM
Mais detalhes de Hoth Therapeutics Inc Empresa
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
Informações de Hoth Therapeutics Inc
Código da empresaHOTH
Nome da EmpresaHoth Therapeutics Inc
Data de listagemFeb 15, 2019
CEOKnie (Robb)
Número de funcionários2
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 15
Endereço1177 Avenue Of The Americas
CidadeNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10036
Telefone16467562997
Sitehttps://hoththerapeutics.com/
Código da empresaHOTH
Data de listagemFeb 15, 2019
CEOKnie (Robb)
Executivos da empresa Hoth Therapeutics Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jeff Pavell
Dr. Jeff Pavell
Independent Director
Independent Director
5.08K
--
Mr. Wayne Linsley
Mr. Wayne Linsley
Independent Director
Independent Director
134.00
--
Mr. Robb Knie
Mr. Robb Knie
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David Sarnoff
Mr. David Sarnoff
Independent Director
Independent Director
--
--
Mr. David S. Briones
Mr. David S. Briones
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Camarra
Mr. Chris Camarra
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jeff Pavell
Dr. Jeff Pavell
Independent Director
Independent Director
5.08K
--
Mr. Wayne Linsley
Mr. Wayne Linsley
Independent Director
Independent Director
134.00
--
Mr. Robb Knie
Mr. Robb Knie
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David Sarnoff
Mr. David Sarnoff
Independent Director
Independent Director
--
--
Mr. David S. Briones
Mr. David S. Briones
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Camarra
Mr. Chris Camarra
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Hoth Therapeutics Inc?
Os cinco principais acionistas de Hoth Therapeutics Inc são: Dr. Jeff Pavell
Quantas instituições possuem ações da Hoth Therapeutics Inc (HOTH)?
Em 2026Q1, 43 instituições possuíam ações da Hoth Therapeutics Inc, com valor de mercado aproximado de 1.30M, representando 6.79% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -245182.00.